SCHEMBL24915849

SCHEMBL24915849

CCc1cc(C(=O)NC)c2nccc(C(C)C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.37
SLC40A1 Q9NP59 2/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSP90AA1 P07900 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
HSP90AB1 P08238 2/20 0.34
RIOK2 Q9BVS4 1/20 0.33
ALOX12 P18054 1/20 0.33
LCLAT1 Q6UWP7 1/20 0.33
POLB P06746 2/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915532 0.86 LMNA (0.48) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL24915997 0.86 GPR52 (0.39) ALDH1A1BRD4
SCHEMBL24916411 0.86 ACE2 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL24915998 0.85 SMYD3 (0.47) RAB9AALDH1A1BRD4
SCHEMBL24916013 0.85 MAP4K4 (0.40) L3MBTL1HSP90AB1
SCHEMBL24916033 0.85 RAB9A (0.43) NPC1RAB9AALDH1A1SMN1; SMN2CYP1A2
SCHEMBL24916409 0.84 GABRA1 (0.43) NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL24916027 0.83 CSNK2A2 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2CYP1A2
SCHEMBL24916002 0.83 SMYD3 (0.43) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL24915854 0.80 MTNR1A (0.43) PLK1ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 PLK1 264/4885SLC40A1 4365/4885NPC1 1407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.